BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2855 related articles for article (PubMed ID: 28404623)

  • 21. Nonculprit Lesion Plaque Morphology in Patients With ST-Segment-Elevation Myocardial Infarction: Results From the COMPLETE Trial Optical Coherence Tomography Substudys.
    Pinilla-Echeverri N; Mehta SR; Wang J; Lavi S; Schampaert E; Cantor WJ; Bainey KR; Welsh RC; Kassam S; Mehran R; Storey RF; Nguyen H; Meeks B; Wood DA; Cairns JA; Sheth T
    Circ Cardiovasc Interv; 2020 Jul; 13(7):e008768. PubMed ID: 32646305
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Angiographic Severity of the Nonculprit Lesion and the Efficacy of Fractional Flow Reserve-Guided Complete Revascularization in Patients With AMI: FRAME-AMI Substudy.
    Seung J; Choo EH; Kim CJ; Kim HK; Park KH; Lee SH; Kim MC; Hong YJ; Ahn SG; Doh JH; Lee SY; Park SD; Lee HJ; Kang MG; Koh JS; Cho YK; Nam CW; Koo BK; Lee BK; Yun KH; Hong D; Joh HS; Choi KH; Park TK; Lee JM; Yang JH; Song YB; Choi SH; Gwon HC; Hahn JY;
    Circ Cardiovasc Interv; 2024 Jan; 17(1):e013611. PubMed ID: 37929584
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Angiography-guided Multivessel Percutaneous Coronary Intervention Versus Ischemia-guided Percutaneous Coronary Intervention Versus Medical Therapy in the Management of Significant Disease in Non-Infarct-related Arteries in ST-Elevation Myocardial Infarction Patients With Multivessel Coronary Disease.
    Perera D; Crake T; Lee V
    Crit Pathw Cardiol; 2018 Jun; 17(2):77-82. PubMed ID: 29768315
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immediate versus staged complete myocardial revascularization in patients with ST-segment elevation myocardial infarction and multivessel disease: A post hoc analysis of the randomized FLOWER-MI trial.
    Tea V; Morelle JF; Gallet R; Cayla G; Lemesle G; Lhermusier T; Dillinger JG; Ducrocq G; Angouvant D; Cottin Y; Chamandi C; le Bras A; Steg PG; Montalescot G; Nelson AC; Simon T; Chatellier G; Danchin N; Puymirat E;
    Arch Cardiovasc Dis; 2022 Oct; 115(10):496-504. PubMed ID: 36096979
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical outcomes of complete revascularization using either angiography-guided or fractional flow reserve-guided drug-eluting stent implantation in non-culprit vessels in ST elevation myocardial infarction patients: insights from a study based on a systematic review and meta-analysis.
    Hideo-Kajita A; Garcia-Garcia HM; Kuku KO; Beyene SS; Azizi V; Meirovich YF; Melaku GD; Dheendsa A; Brathwaite EJ; Desale S; Soud M; Dan K; Ozaki Y; Waksman R; Lipinski M
    Int J Cardiovasc Imaging; 2018 Sep; 34(9):1349-1364. PubMed ID: 29779179
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of multivessel coronary artery disease on reperfusion success in patients with ST-elevation myocardial infarction: A substudy of the AIDA STEMI trial.
    de Waha S; Eitel I; Desch S; Fuernau G; Pöss J; Schuler G; Thiele H
    Eur Heart J Acute Cardiovasc Care; 2017 Oct; 6(7):592-600. PubMed ID: 26691729
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Complete vs Culprit-Lesion-Only Revascularization for ST-Segment Elevation Myocardial Infarction: A Systematic Review and Meta-analysis.
    Bainey KR; Engstrøm T; Smits PC; Gershlick AH; James SK; Storey RF; Wood DA; Mehran R; Cairns JA; Mehta SR
    JAMA Cardiol; 2020 Aug; 5(8):881-888. PubMed ID: 32432651
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cost-Effectiveness of Fractional Flow Reserve-Guided Treatment for Acute Myocardial Infarction and Multivessel Disease: A Prespecified Analysis of the FRAME-AMI Randomized Clinical Trial.
    Hong D; Lee SH; Lee J; Lee H; Shin D; Kim HK; Park KH; Choo EH; Kim CJ; Kim MC; Hong YJ; Jeong MH; Ahn SG; Doh JH; Lee SY; Don Park S; Lee HJ; Kang MG; Koh JS; Cho YK; Nam CW; Choi KH; Park TK; Yang JH; Song YB; Choi SH; Gwon HC; Guallar E; Cho J; Hahn JY; Kang D; Lee JM;
    JAMA Netw Open; 2024 Jan; 7(1):e2352427. PubMed ID: 38270954
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vessel fractional flow reserve-based non-culprit lesion reclassification in patients with ST-segment elevation myocardial infarction: Impact on treatment strategy and clinical outcome (FAST STEMI I study).
    Groenland FTW; Huang J; Scoccia A; Neleman T; Ziedses Des Plantes AC; Nuis RJ; den Dekker WK; Wilschut JM; Diletti R; Kardys I; Van Mieghem NM; Daemen J
    Int J Cardiol; 2023 Feb; 373():33-38. PubMed ID: 36436683
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multivessel Versus Culprit-only Percutaneous Coronary Intervention in ST-segment Elevation Acute Myocardial Infarction: Analysis of an 8-year Registry.
    Galvão Braga C; Cid-Álvarez AB; Redondo Diéguez A; Trillo-Nouche R; Álvarez Álvarez B; López Otero D; Ocaranza Sánchez R; Gestal Romaní S; González Ferreiro R; González-Juanatey JR
    Rev Esp Cardiol (Engl Ed); 2017 Jun; 70(6):425-432. PubMed ID: 27825718
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fractional Flow Reserve-Guided Multivessel Angioplasty in Myocardial Infarction.
    Smits PC; Abdel-Wahab M; Neumann FJ; Boxma-de Klerk BM; Lunde K; Schotborgh CE; Piroth Z; Horak D; Wlodarczak A; Ong PJ; Hambrecht R; Angerås O; Richardt G; Omerovic E;
    N Engl J Med; 2017 Mar; 376(13):1234-1244. PubMed ID: 28317428
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vessel fractional flow reserve in assessment of non-culprit lesions in ST elevation myocardial infarction.
    Chang CC; Chuang MJ; Lee YH; Tsai YL; Lu YW; Chou RH; Wu CH; Lu TM; Huang PH; Lin SJ
    Open Heart; 2021 Jul; 8(2):. PubMed ID: 34341096
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical Outcomes and Cost-Effectiveness of Fractional Flow Reserve-Guided Percutaneous Coronary Intervention in Patients With Stable Coronary Artery Disease: Three-Year Follow-Up of the FAME 2 Trial (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation).
    Fearon WF; Nishi T; De Bruyne B; Boothroyd DB; Barbato E; Tonino P; Jüni P; Pijls NHJ; Hlatky MA;
    Circulation; 2018 Jan; 137(5):480-487. PubMed ID: 29097450
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of Long-Term Clinical Outcome Between Multivessel Percutaneous Coronary Intervention Versus Infarct-Related Artery-Only Revascularization for Patients With ST-Segment-Elevation Myocardial Infarction With Cardiogenic Shock.
    Lee JM; Rhee TM; Kim HK; Hwang D; Lee SH; Choi KH; Kim J; Park TK; Yang JH; Song YB; Choi JH; Choi SH; Koo BK; Chae SC; Cho MC; Kim CJ; Kim JH; Kim HS; Gwon HC; Jeong MH; Hahn JY;
    J Am Heart Assoc; 2019 Dec; 8(24):e013870. PubMed ID: 31818215
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design and rationale of the COMPARE-ACUTE trial: Fractional flow reserve-guided primary multivessel percutaneous coronary intervention to improve guideline indexed actual standard of care for treatment of ST-elevation myocardial infarction in patients with multivessel coronary disease.
    Smits PC; Assaf A; Richardt G; Omerovic E; Abdel-Wahab M; Neumann FJ
    Am Heart J; 2017 Apr; 186():21-28. PubMed ID: 28454829
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Culprit Vessel Versus Multivessel Versus In-Hospital Staged Intervention for Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Disease: Stratified Analyses in High-Risk Patient Groups and Anatomic Subsets of Nonculprit Disease.
    Iqbal MB; Nadra IJ; Ding L; Fung A; Aymong E; Chan AW; Hodge S; Della Siega A; Robinson SD;
    JACC Cardiovasc Interv; 2017 Jan; 10(1):11-23. PubMed ID: 28057282
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Culprit Vessel-Only Versus Multivessel Percutaneous Coronary Intervention in Patients With Cardiogenic Shock Complicating ST-Segment-Elevation Myocardial Infarction: A Collaborative Meta-Analysis.
    Kolte D; Sardar P; Khera S; Zeymer U; Thiele H; Hochadel M; Radovanovic D; Erne P; Hambraeus K; James S; Claessen BE; Henriques JPS; Mylotte D; Garot P; Aronow WS; Owan T; Jain D; Panza JA; Frishman WH; Fonarow GC; Bhatt DL; Aronow HD; Abbott JD
    Circ Cardiovasc Interv; 2017 Nov; 10(11):. PubMed ID: 29146672
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Culprit-only versus staged complete revascularization for patients with ST-segment elevation myocardial infarction and Multivessel disease: a retrospective cohort study.
    Yu T; Dong Y; Zhu J; Tian C; Sun Z; Sun Z
    BMC Cardiovasc Disord; 2016 Oct; 16(1):189. PubMed ID: 27716075
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multivessel Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction With Cardiogenic Shock.
    Lee JM; Rhee TM; Hahn JY; Kim HK; Park J; Hwang D; Choi KH; Kim J; Park TK; Yang JH; Song YB; Choi JH; Choi SH; Koo BK; Kim YJ; Chae SC; Cho MC; Kim CJ; Gwon HC; Kim JH; Kim HS; Jeong MH;
    J Am Coll Cardiol; 2018 Feb; 71(8):844-856. PubMed ID: 29471935
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FFR Derived From Coronary CT Angiography in Nonculprit Lesions of Patients With Recent STEMI.
    Gaur S; Taylor CA; Jensen JM; Bøtker HE; Christiansen EH; Kaltoft AK; Holm NR; Leipsic J; Zarins CK; Achenbach S; Khem S; Wilk A; Bezerra HG; Lassen JF; Nørgaard BL
    JACC Cardiovasc Imaging; 2017 Apr; 10(4):424-433. PubMed ID: 27743953
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 143.